Sudeep Pharma
add_icon

Sudeep Pharma

644.20
+12.60
(1.99%)
Market Cap
7,276.15 Cr
PE Ratio
41.87
Volume
2,79,133.00
Day High - Low
662.75 - 605.50
52W High-Low
795.00 - 524.05
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
7,276.15 Cr
EPS
12.79
PE Ratio
41.87
PB Ratio
8.67
Book Value
72.66
EBITDA
199.30
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
28.13
Debt to Equity
0.25
Analyst Rating and Forecast
- By Refinitiv from1 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
positive
Sudeep Pharma Limited published consolidated financial results for Q3 FY26, showing significant growth in revenue and profitability with regulatory compliance announcements.
neutral
Sudeep Pharma Limited has rescheduled its earnings call with analysts and investors to February 9, 2026 at 11:00 AM IST to discuss Q3FY26 operational and financial performance.
neutral
Sudeep Pharma announces resignation of Sales & Supply Chain VP John Garcia, effective February 6, 2026, as he pursues new career opportunities in leadership transition.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,731.80
#1 4,15,516.83
37.95
#1 54,729.00
9.71
#1 10,980
16.07
59.87
6,255.50
1,66,063.87
67.41
9,712.00
18.67
2,191
-1.02
51.90
4,397.90
1,48,844.92
64.23
11,539.40
6.99
1,911
26.24
74.38
1,300.20
1,08,518.64
19.75
33,741.20
16.73
5,725
-15.28
63.44
1,326.70
1,07,167.08
23.63
28,409.50
7.12
5,291
-57.18
39.70
2,250.20
1,02,788.87
21.98
22,909.50
13.74
3,306
#1 37.44
62.92
903.85
90,948.46
#1 18.18
23,511.00
18.55
4,615
-0.32
50.54
2,054.70
84,819.06
46.85
12,744.20
#1 20.90
2,007
7.65
44.08
1,164.40
67,628.54
19.17
32,345.60
9.43
3,484
7.59
48.85
5,495.50
65,706.95
27.11
13,458.30
3.70
2,216
1.90
44.08
Growth Rate
Revenue Growth
9.86 %
Net Income Growth
4.13 %
Cash Flow Change
-25.82 %
ROE
-24.83 %
ROCE
-26.70 %
EBITDA Margin (Avg.)
-3.40 %

Quarterly Financial Results

Quarterly Financials
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
81
151
118
161
130
173
179
Expenses
52
85
76
99
81
107
112
EBITDA
30
65
42
63
49
66
67
Operating Profit %
35 %
43 %
34 %
37 %
35 %
34 %
35 %
Depreciation
3
3
3
3
3
4
4
Interest
2
1
1
2
2
2
1
Profit Before Tax
26
62
38
58
44
60
62
Tax
9
13
9
14
13
13
14
Net Profit
17
49
29
44
31
47
48
EPS in ₹
4.49
4.49
2.65
4.54
2.84
4.20
4.29

Balance Sheet

Balance Sheet
2020
2021
2022
2024
2025
Total Assets
131
213
344
514
717
Fixed Assets
60
68
137
180
189
Current Assets
56
100
197
275
424
Capital Work in Progress
8
24
8
45
88
Investments
0
0
0
0
0
Other Assets
63
121
199
289
440
Total Liabilities
131
213
344
514
717
Current Liabilities
37
80
147
137
175
Non Current Liabilities
13
19
34
21
49
Total Equity
81
114
163
356
493
Reserve & Surplus
80
113
162
355
481
Share Capital
1
1
1
1
12

Cash Flow

Cash Flow
2020
2021
2022
2024
2025
Net Cash Flow
-0
8
10
4
23
Investing Activities
-23
-40
-38
-49
-79
Operating Activities
10
35
-3
66
49
Financing Activities
12
13
51
-13
53

Share Holding

% Holding
Jun 2025
Nov 2025
Dec 2025
Promoter
91.07 %
76.15 %
76.15 %
FIIs
0.00 %
1.54 %
1.67 %
DIIs
0.00 %
14.76 %
17.60 %
Government
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
7.52 %
3.27 %
Others
8.93 %
0.02 %
1.31 %
No of Share Holders
0
16
43,599

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
19 Dec 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
19 Dec 2025 698.20 672.95
06 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Feb 2026 593.90 618.30

Announcements

Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 12, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 09, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 09, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 07, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 07, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 07, 2026
Un-Audited Financial Results As On 31.12.2025Feb 06, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 06.02.2026Feb 06, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 05, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 02, 2026
Board Meeting Intimation for Approval Of Unaudited Financial Results As On 31St December 2025 Along With Other Business ItemsFeb 02, 2026
Announcement Under Regulation 30 (LODR) - Intimation Of Approval For Purchase Of Rights In Leasehold Land In GIDC By Sudeep Advanced Materials Private Limited A Wholly Owned Subsidiary (WOS) Of The Company.Jan 22, 2026
General UpdateJan 16, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2026
Closure of Trading WindowDec 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeDec 22, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationDec 21, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 20, 2025
Submission Of Financials As On Quarter And Half Year Ended 30Th September 2025Dec 19, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 19Th December 2025Dec 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 15, 2025
Board Meeting Intimation for Adoption Of Unaudited Financial Results For The Quarter And Half Year Ended On September 30 2025 And Other Business ItemsDec 15, 2025
Intimation Of Unsecured Loan Granted To Sudeep Advanced Materials Private Limited A Wholly Owned Subsidiary (WOS) Of The CompanyDec 09, 2025
Closure of Trading WindowNov 28, 2025
Listing of Equity Shares of Sudeep Pharma LtdNov 28, 2025

Technical Indicators

RSI(14)
Neutral
47.87
ATR(14)
Volatile
25.44
STOCH(9,6)
Neutral
61.43
STOCH RSI(14)
Neutral
51.01
MACD(12,26)
Bullish
1.40
ADX(14)
Strong Trend
33.32
UO(9)
Bearish
49.27
ROC(12)
Uptrend And Accelerating
2.15
WillR(14)
Neutral
-61.30